Pharmalucence, Inc. has entered into an agreement with Lantheus Medical Imaging to manufacture DEFINITY Vial for (Perflutren Lipid Microsphere) Injectable Suspension for contrast-enhanced echocardiography. Pharmalucence will provide manufacturing at its new drug production facility in Billerica, MA for a minimum of 10 years.    Ed Connolly, chief operating officer of Pharmalucence, said, “Pharmalucence has established a world-class manufacturing facility here in New England, which has been recog...